Routine vitamin D and calcium supplementation in older adults is not supported for lowering the incidence of osteoporosis-related fractures.
In patients with hip fractures, the use of a regional nerve block may provide pain relief, and decrease the risk for pneumonia.
Growth hormone therapy may reduce the risk for fracture in patients with osteoporosis.
A new bone assessment evaluates fracture risk in children.
Daily B vitamins and folic acid do not affect fracture risk in women with preexisting CV disease.
In young adults, fractures are mainly caused by severe trauma.
Patients with a history of tuberculosis are at higher risk for developing osteoporosis or osteoporotic fractures.
Study used the University of Utah Health Care electronic health record (EHR) database, which contained data from 1.6 million patients.
Testosterone treatments help improve volumetric bone mineral density and bone strength in elderly men with low testosterone.
Study examines the predictive value for vertebral fractures of bone mineral density and bone turnover markers after a 5-year drug holiday.
A retrospective study examined the risk of developing fractures in postmenopausal women with osteoporosis who discontinued bisphosphonate therapy.
Low serum levels of dehydroepiandrosterone, DHEA, and it's sulfate (DHEAS) in older men are markers for osteoporotic fracture risk, researchers say.
Prospective study examines women with a history of gout and risk of hip and wrist fractures.
High-inflammation diets were associated with greater bone density loss in a recent observational study.
Smartphone-based teleradiology may potentially be used for consultations with specialists to increase access to care.
Cardiovascular disease, stroke, diabetes, hip and knee replacements, and both behavioral and mental disorders were also more common in the AD cohort.
Less frequent dosing with zoledronic acid does not increase fracture risk in patients with bone metastases.
The risk of hip fracture with diabetes was attenuated after allowing for the competing risk of death.
Continuous long-term dipeptidyl peptidase-4 inhibitor use was not found to be associated with risk of any, osteoporotic, or hip fracture.
Posthoc analysis of randomized clinical trial data confirms the association between thiazide use for hypertension and a decreased risk of hospitalization for fracture.
Heavy cannabis use is associated with low bone mineral density, high bone turnover, and an increased risk of fracture.
The cost-effectiveness of orthogeriatric and nurse-led fracture liaison service was evaluated for post-hip fracture care.
A modest reduction in risk for fracture was noted with calcium plus vitamin D supplements, but the effect on cardiovascular outcomes was unclear.
The use of ARBs was associated with lower incidence of non-vertebral fractures than ACE inhibitors or CCBs.
Abaloparatide reduced risk of vertebral fractures in postmenopausal women with osteoporosis over 18 months compared to placebo.
Patients with rheumatoid arthritis have an overestimated risk of fracture when measured with the United Kingdom Fracture Risk Assessment Tool compared with the general population.
Advanced glycation endproducts were linked to reduced bone material properties in postmenopausal women with type 2 diabetes.
Daily intake of one or less servings of fruit and vegetables linked to increased risk in older adults
The efficacy and safety of abaloparatide was studied in a randomized, double-blind, multicenter trial evaluating fracture prevention in ambulatory, postmenopausal women with osteoporosis.
Analysis of data from the Women's Health Initiative found an association between the Mediterranean diet and risk of hip fracture in postmenopausal women.
Rheumatology Advisor Articles
- Large Vessel Vasculitis Imaging: Recommendations for Clinical Practice
- Salivary Gland Ultrasound Scores Improved With Rituximab in Primary Sjogren's Syndrome
- Joint Replacement Rates in OA With Diabetes: Effects of COX-2 Inhibitors Plus Metformin
- Imaging Changes Examined in Tocilizumab-Treated Polymyalgia Rheumatica
- Cancer Immunotherapy Outcomes Evaluated in Patients With Rheumatic Disease
- FDA Advises Recall: Limbrel May Be Linked to Drug-Induced Liver Injury
- Allopurinol Use May Lower Risk for Peripheral Arterial Disease
- Managing Treatment Nonadherence in Rheumatic Diseases
- Optimal Fibromyalgia Management Includes Individualized, Multimodal Therapy
- Risk for COPD, Asthma Among Women With Rheumatoid Arthritis: Nurses' Health Study
- Raynaud Phenomenon, Migraine Linked to aPS/PT Antibodies in Primary Antiphospholipid Syndrome
- Treating Violence as a Contagious Health Problem
- Factors of Plasma Ropivacaine Concentrations After Local Infiltration Analgesia in TKA
- Anti-CCP Positivity Associated With Increased Risk of Major Fracture in RA
- Then and Now: The Crisis of Physician Suicides